PHATHOM PHARMACEUTICALS, INC. (PHAT) Total liabilities 2022–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) total liabilities at each fiscal year-end, per SEC filings.
$697.3MFY2025 · since FY2022: $239.6M → $697.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $697.3M | +10.4% |
| FY2024 | $631.9M | +29.9% |
| FY2023 | $486.6M | +103.1% |
| FY2022 | $239.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice